Phase 3 study of pemetrexed-platinum with or without pembrolizumab for TKI-resistant/EGFR-mutated advanced NSCLC: KEYNOTE-789 Meeting Abstract
| Authors: | Riely, G.; Hui, R.; Carbone, D.; Park, K.; Carrigan, M.; Xu, X.; Dang, T.; Yang, J. C. H. |
| Abstract Title: | Phase 3 study of pemetrexed-platinum with or without pembrolizumab for TKI-resistant/EGFR-mutated advanced NSCLC: KEYNOTE-789 |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | nsclc; egfr mutation; pembrolizumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S494 |
| Language: | English |
| ACCESSION: | WOS:000454014501271 |
| DOI: | 10.1016/j.jtho.2018.08.637 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.01-81 -- Source: Wos |
